Chat with us, powered by LiveChat

Accelerating safety assessments for carcinogenicity with Kaptis

Ellam, A; Cayley, A; Barber, CG; Fowkes, A; Scrafton, EJ; Reeves, AF;

Discover how Kaptis helps you to assess the risk of human adverse events by organising knowledge through Adverse Outcome Pathways (AOPs).

Kaptis supports regulatory decision-making at all stages for ICH S1B. This infographic demonstrates how using Kaptis ICH S1 functionality within a Weight of Evidence assessment can reduce or eliminate the need for a traditional two-year rat carcinogenicity study.